Skip to main content
Erschienen in: Cancer Causes & Control 10/2008

01.12.2008 | Review Article

Physical activity as a negative modulator of estrogen-induced breast cancer

verfasst von: Yvonne M. Coyle

Erschienen in: Cancer Causes & Control | Ausgabe 10/2008

Einloggen, um Zugang zu erhalten

Abstract

Physical activity is a protective factor for breast cancer. Exposure to estrogen is an important determinant of breast cancer risk and exercise reduces estrogen levels, with the level of evidence being stronger for post-menopausal women. Possible mechanisms for estrogen induced breast cancer include increased breast epithelial cell proliferation, the metabolism of estrogen to genotoxic metabolites, such as DNA-adducts, and the silencing of tumor suppressor genes (TSGs) that have been implicated in breast carcinogenesis by inducing gene promoter hypermethylation, which is potentially reversible. Animal studies suggest that physical activity decreases breast tumor growth by promoting changes in cellular proliferation and apoptosis. Human studies provide some support for exercise producing favorable changes in estrogen metabolism that may lead to reduced breast epithelial cell proliferation. No studies have been performed to determine whether exercise decreases the accumulation of estrogen metabolite DNA-adducts in breast tissue. However, research supports the hypothesis that physical activity reduces promoter hypermethylation of TSGs implicated in breast carcinogenesis by lowering circulating estrogen levels. Thus, further research is necessary to clarify the mechanisms that relate to physical activity as a negative modulator of breast cancer risk to develop meaningful guidelines for the use of physical activity in breast cancer prevention.
Literatur
1.
Zurück zum Zitat World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DC World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DC
2.
Zurück zum Zitat International Agency for Research on Cancer (2002) IARC handbooks of cancer prevention, vol 6. Weight control and physical activity. IARC Press, Lyon International Agency for Research on Cancer (2002) IARC handbooks of cancer prevention, vol 6. Weight control and physical activity. IARC Press, Lyon
3.
Zurück zum Zitat Adams-Campbell LL, Rosenberg L, Rao RS, Palmer JR (2001) Strenuous physical activity and breast cancer risk in African-American women. J Natl Med Assoc 93:267–275PubMed Adams-Campbell LL, Rosenberg L, Rao RS, Palmer JR (2001) Strenuous physical activity and breast cancer risk in African-American women. J Natl Med Assoc 93:267–275PubMed
4.
Zurück zum Zitat John EM, Horn-Ross PL, Koo J (2003) Lifetime physical activity and breast cancer risk in a multiethnic population, The San Francisco Bay Area Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 12:1143–1152PubMed John EM, Horn-Ross PL, Koo J (2003) Lifetime physical activity and breast cancer risk in a multiethnic population, The San Francisco Bay Area Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 12:1143–1152PubMed
6.
Zurück zum Zitat Ueji M, Ueno E, Osei-Hyiaman D, Takahashi H, Kano K (1997) Physical activity and the risk of breast cancer, a case–control study of Japanese women. J Epidemiol 8:115–122 Ueji M, Ueno E, Osei-Hyiaman D, Takahashi H, Kano K (1997) Physical activity and the risk of breast cancer, a case–control study of Japanese women. J Epidemiol 8:115–122
12.
Zurück zum Zitat Cohen LA, Choi K, Wang CX (1988) Influence of dietary fat, caloric restriction, and voluntary exercise on N-nitrosomethylurea-induced mammary tumorigenesis in rats. Cancer Res 48:4276–4283PubMed Cohen LA, Choi K, Wang CX (1988) Influence of dietary fat, caloric restriction, and voluntary exercise on N-nitrosomethylurea-induced mammary tumorigenesis in rats. Cancer Res 48:4276–4283PubMed
13.
Zurück zum Zitat Cohen LA, Choi K, Backlund JY, Harris R, Wang CX (1991) Modulation of N-nitrosomethylurea induced mammary tumorigenesis by dietary fat and voluntary exercise. In Vivo 5:333–344PubMed Cohen LA, Choi K, Backlund JY, Harris R, Wang CX (1991) Modulation of N-nitrosomethylurea induced mammary tumorigenesis by dietary fat and voluntary exercise. In Vivo 5:333–344PubMed
14.
Zurück zum Zitat Cohen LA, Kendall ME, Meschter C, Epstein MA, Reinhardt J, Zang E (1993) Inhibition of rat mammary tumorigenesis by voluntary exercise. In Vivo 7:151–158PubMed Cohen LA, Kendall ME, Meschter C, Epstein MA, Reinhardt J, Zang E (1993) Inhibition of rat mammary tumorigenesis by voluntary exercise. In Vivo 7:151–158PubMed
15.
Zurück zum Zitat Thompson HJ (1994) Effect of exercise intensity and duration on the induction of mammary carcinogenesis. Cancer Res 54:1960s–1963sPubMed Thompson HJ (1994) Effect of exercise intensity and duration on the induction of mammary carcinogenesis. Cancer Res 54:1960s–1963sPubMed
16.
Zurück zum Zitat Thompson HJ, Westerlind KC, Snedden J, Briggs S, Meenakshi S (1995) Exercise intensity dependent inhibition of 1-methyl-1-nitrosourea induced mammary carcinogenesis in female F-344 rats. Carcinogenesis 16(8):1783–1786PubMedCrossRef Thompson HJ, Westerlind KC, Snedden J, Briggs S, Meenakshi S (1995) Exercise intensity dependent inhibition of 1-methyl-1-nitrosourea induced mammary carcinogenesis in female F-344 rats. Carcinogenesis 16(8):1783–1786PubMedCrossRef
17.
Zurück zum Zitat Whittal KS, Parkhouse WS (1996) Exercise during adolescence and its effects on mammary gland development, proliferation, and nitrosomethylurea (NMU) induced tumorigenesis in rats. Breast Cancer Res Treat 37:21–27. doi:10.1007/BF01806628 PubMedCrossRef Whittal KS, Parkhouse WS (1996) Exercise during adolescence and its effects on mammary gland development, proliferation, and nitrosomethylurea (NMU) induced tumorigenesis in rats. Breast Cancer Res Treat 37:21–27. doi:10.​1007/​BF01806628 PubMedCrossRef
20.
Zurück zum Zitat Pike MC, Henderson BE, Casagrande JT (1981) The epidemiology of breast cancer as it relates to menarche, pregnancy and menopause. In: Pike MC, Siiter PK, Welsh C (eds) Hormones and breast cancer. Cold Spring Harbor Laboratory, New York, pp 3–13 Pike MC, Henderson BE, Casagrande JT (1981) The epidemiology of breast cancer as it relates to menarche, pregnancy and menopause. In: Pike MC, Siiter PK, Welsh C (eds) Hormones and breast cancer. Cold Spring Harbor Laboratory, New York, pp 3–13
22.
Zurück zum Zitat Coyle YM, Xie X-J, Lewis CM, Bu D, Milchgrub S, Euhus D (2006) Role of physical activity in modulating breast cancer risk as defined by APC and RASSF1A promoter hypermethylation in non-malignant breast tissue. Cancer Epidemiol Biomarkers Prev 16:192–196. doi:10.1158/1055-9965.EPI-06-0700 CrossRef Coyle YM, Xie X-J, Lewis CM, Bu D, Milchgrub S, Euhus D (2006) Role of physical activity in modulating breast cancer risk as defined by APC and RASSF1A promoter hypermethylation in non-malignant breast tissue. Cancer Epidemiol Biomarkers Prev 16:192–196. doi:10.​1158/​1055-9965.​EPI-06-0700 CrossRef
23.
24.
Zurück zum Zitat Lonning PE, Helle SI, Johannessen DC, Ekse E, Adlercreutz H (1996) Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer. Breast Cancer Res Treat 29:335–341. doi:10.1007/BF01806162 CrossRef Lonning PE, Helle SI, Johannessen DC, Ekse E, Adlercreutz H (1996) Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer. Breast Cancer Res Treat 29:335–341. doi:10.​1007/​BF01806162 CrossRef
25.
Zurück zum Zitat Combined Hormone Trialists’ Group the European Organization for Research, Treatment of Cancer (2001) Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist along in premenopausal advanced breast cancer, a meta-analysis of four randomized trials. J Clin Oncol 19:343–353 Combined Hormone Trialists’ Group the European Organization for Research, Treatment of Cancer (2001) Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist along in premenopausal advanced breast cancer, a meta-analysis of four randomized trials. J Clin Oncol 19:343–353
26.
Zurück zum Zitat Hankinson SE (2005/2006) Endogenous hormones and risk of breast cancer in postmenopausal women. Breast Dis 24:3–15 Hankinson SE (2005/2006) Endogenous hormones and risk of breast cancer in postmenopausal women. Breast Dis 24:3–15
27.
Zurück zum Zitat The Endogenous Hormones Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women, reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616 The Endogenous Hormones Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women, reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616
28.
Zurück zum Zitat Siiteri PK (1987) Adipose tissue as a source of hormones. Am J Clin Nutr 45:277–282PubMed Siiteri PK (1987) Adipose tissue as a source of hormones. Am J Clin Nutr 45:277–282PubMed
30.
Zurück zum Zitat Wysowski DK, Comstock GW, Helsing KJ, Lau HL (1987) Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemol 125(5):791–799 Wysowski DK, Comstock GW, Helsing KJ, Lau HL (1987) Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemol 125(5):791–799
31.
Zurück zum Zitat Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW (1994) A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 18:79–85PubMed Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW (1994) A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 18:79–85PubMed
32.
Zurück zum Zitat Rosenberg CR, Pasternack BS, Shore RE, Koenig KL, Toniolo PG (1994) Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol 140(6):518–525PubMed Rosenberg CR, Pasternack BS, Shore RE, Koenig KL, Toniolo PG (1994) Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol 140(6):518–525PubMed
33.
Zurück zum Zitat Thomas HV, Key TJ, Allen DS et al (1997) A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 75(7):1075–1079PubMed Thomas HV, Key TJ, Allen DS et al (1997) A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 75(7):1075–1079PubMed
34.
Zurück zum Zitat Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE (2000) A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomarkers Prev 9:575–579PubMed Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE (2000) A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomarkers Prev 9:575–579PubMed
35.
Zurück zum Zitat Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C et al (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst 97(10):755–765PubMedCrossRef Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C et al (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst 97(10):755–765PubMedCrossRef
36.
Zurück zum Zitat Eliassen AH, Missmer SA, Tworoger SS et al (2005) Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 98:1406–1415 Eliassen AH, Missmer SA, Tworoger SS et al (2005) Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 98:1406–1415
37.
Zurück zum Zitat Russell J, Mitchell D, Musey PI, Collins DC (1984) The relationship of exercise to anovulatory cycles in female athletes: hormonal and physical characteristics. Obstet Gynecol 63:452–456PubMed Russell J, Mitchell D, Musey PI, Collins DC (1984) The relationship of exercise to anovulatory cycles in female athletes: hormonal and physical characteristics. Obstet Gynecol 63:452–456PubMed
38.
Zurück zum Zitat Broocks A, Pirke KM, Schweiger U, Tuschl RJ, Laessle RG, Strowitzki T et al (1990) Cyclic ovarian function in recreational athletes. J Appl Physiol 68(5):2083–2086PubMed Broocks A, Pirke KM, Schweiger U, Tuschl RJ, Laessle RG, Strowitzki T et al (1990) Cyclic ovarian function in recreational athletes. J Appl Physiol 68(5):2083–2086PubMed
40.
Zurück zum Zitat Bullen BA, Skrinar GS, Beitins IZ, von Mering G, Turnbull BA, McArthur JW (1985) Induction of menstrual disorders by strenuous exercise in untrained women. N Engl J Med 312:1349–1353PubMed Bullen BA, Skrinar GS, Beitins IZ, von Mering G, Turnbull BA, McArthur JW (1985) Induction of menstrual disorders by strenuous exercise in untrained women. N Engl J Med 312:1349–1353PubMed
41.
Zurück zum Zitat Beitins IZ, McArthur JW, Turnbull BA, Skrinar GS, Bullen BA (1991) Exercise induces two types of human luteal dysfunction: confirmation by urinary free progesterone. J Clin Endocrinol Metab 72:1350–1358PubMed Beitins IZ, McArthur JW, Turnbull BA, Skrinar GS, Bullen BA (1991) Exercise induces two types of human luteal dysfunction: confirmation by urinary free progesterone. J Clin Endocrinol Metab 72:1350–1358PubMed
44.
Zurück zum Zitat Tworoger SS, Missmer SA, Eliassen AH, Barbieri RL, Dowsett M, Hankinson SE (2007) Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women. Cancer Causes Control 18:743–752. doi:10.1007/s10552-007-9017-5 PubMedCrossRef Tworoger SS, Missmer SA, Eliassen AH, Barbieri RL, Dowsett M, Hankinson SE (2007) Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women. Cancer Causes Control 18:743–752. doi:10.​1007/​s10552-007-9017-5 PubMedCrossRef
45.
Zurück zum Zitat Nelson ME, Meredith CN, Dawson-Hughes B, Evans WJ (1988) Hormone and bone mineral status in endurance-trained and sedentary postmenopausal women. J Clin Endocrinol Metab 66:927–933PubMed Nelson ME, Meredith CN, Dawson-Hughes B, Evans WJ (1988) Hormone and bone mineral status in endurance-trained and sedentary postmenopausal women. J Clin Endocrinol Metab 66:927–933PubMed
46.
Zurück zum Zitat Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG (1989) The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 129:1120–1131PubMed Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG (1989) The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 129:1120–1131PubMed
48.
Zurück zum Zitat Chan M-F, Dowsett M, Folkerd E et al (2007) Usual physical activity and endogenous sex hormones in postmenopausal women: the European prospective investigation into cancer-Norfolk population study. Cancer Epidemiol Biomarkers Prev 16:900–905. doi:10.1158/1055-9965.EPI-06-0745 PubMedCrossRef Chan M-F, Dowsett M, Folkerd E et al (2007) Usual physical activity and endogenous sex hormones in postmenopausal women: the European prospective investigation into cancer-Norfolk population study. Cancer Epidemiol Biomarkers Prev 16:900–905. doi:10.​1158/​1055-9965.​EPI-06-0745 PubMedCrossRef
55.
Zurück zum Zitat Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ (1993) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:1133–1144 Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ (1993) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:1133–1144
58.
Zurück zum Zitat Aiello EJ, Buist DSM, White E (2006) Do breast cancer risk factors modify the association between hormone therapy and mammographic breast density? (United States). Cancer Causes Control 17:1227–1235PubMedCrossRef Aiello EJ, Buist DSM, White E (2006) Do breast cancer risk factors modify the association between hormone therapy and mammographic breast density? (United States). Cancer Causes Control 17:1227–1235PubMedCrossRef
61.
Zurück zum Zitat Atkinson C, Warren R, Bingham A, Day NE (1999) Mammographic patterns as a predictive marker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 8:863–866PubMed Atkinson C, Warren R, Bingham A, Day NE (1999) Mammographic patterns as a predictive marker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 8:863–866PubMed
62.
Zurück zum Zitat Ursin G, Astrahan MA, Salane M et al (1998) The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev 7:43–47PubMed Ursin G, Astrahan MA, Salane M et al (1998) The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev 7:43–47PubMed
63.
64.
Zurück zum Zitat Aiello EJ, Tworoger SS, Yasu Y et al (2005) Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev 14:1411–1417. doi:10.1158/1055-9965.EPI-04-0920 PubMedCrossRef Aiello EJ, Tworoger SS, Yasu Y et al (2005) Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev 14:1411–1417. doi:10.​1158/​1055-9965.​EPI-04-0920 PubMedCrossRef
65.
Zurück zum Zitat Tamini RM, Byrne C, Colditz GA, Hankinson SE (2007) Endogenous hormone levels, mammographic density and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99:1178–1187. doi:10.1093/jnci/djm062 CrossRef Tamini RM, Byrne C, Colditz GA, Hankinson SE (2007) Endogenous hormone levels, mammographic density and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99:1178–1187. doi:10.​1093/​jnci/​djm062 CrossRef
66.
Zurück zum Zitat Boyd NF, Stone J, Martin LJ et al (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87:876–882 Boyd NF, Stone J, Martin LJ et al (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87:876–882
67.
Zurück zum Zitat Greendale GA, Palla SL, Ursin G (2005) The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the postmenopausal estrogen/progestin interventions mammographic density study. Am J Epidemiol 162(9):826–834. doi:10.1093/aje/kwi286 PubMedCrossRef Greendale GA, Palla SL, Ursin G (2005) The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the postmenopausal estrogen/progestin interventions mammographic density study. Am J Epidemiol 162(9):826–834. doi:10.​1093/​aje/​kwi286 PubMedCrossRef
68.
Zurück zum Zitat Gram IT, Funkhouser E, Tabar L (1999) Moderate physical activity in relation to mammographic patterns. Cancer Epidemiol Biomarkers Prev 8:117–122PubMed Gram IT, Funkhouser E, Tabar L (1999) Moderate physical activity in relation to mammographic patterns. Cancer Epidemiol Biomarkers Prev 8:117–122PubMed
69.
Zurück zum Zitat Vachon CM, Kuni CC, Anderson K, Anderson E, Sellers TA (2000) Association of mammographically defined percent breast density with epidemiologic factors for breast cancer (United States). Cancer Causes Control 11:653–662. doi:10.1023/A:1008926607428 PubMedCrossRef Vachon CM, Kuni CC, Anderson K, Anderson E, Sellers TA (2000) Association of mammographically defined percent breast density with epidemiologic factors for breast cancer (United States). Cancer Causes Control 11:653–662. doi:10.​1023/​A:​1008926607428 PubMedCrossRef
70.
Zurück zum Zitat Suijkerbuijk KPM, Van Duijnhoven FJB, Van Gils CH et al (2006) Physical activity in relation to mammographic density on the Dutch prospect-European prospective investigation into cancer and nutrition cohort. Cancer Epidemiol Biomarkers Prev 15:456–460. doi:10.1158/1055-9965.EPI-05-0569 PubMedCrossRef Suijkerbuijk KPM, Van Duijnhoven FJB, Van Gils CH et al (2006) Physical activity in relation to mammographic density on the Dutch prospect-European prospective investigation into cancer and nutrition cohort. Cancer Epidemiol Biomarkers Prev 15:456–460. doi:10.​1158/​1055-9965.​EPI-05-0569 PubMedCrossRef
71.
Zurück zum Zitat Oestriecher N, Capra A, Bromberger J et al (2008) Physical activity and mammographic density in a cohort of midlife women. Med Sci Sports Exerc 40(3):451–466 Oestriecher N, Capra A, Bromberger J et al (2008) Physical activity and mammographic density in a cohort of midlife women. Med Sci Sports Exerc 40(3):451–466
72.
Zurück zum Zitat Lopez P, Van Horn L, Colangelo LA, Wolfman JA, Hendrick RE, Gapstur SM (2003) Physical inactivity and percent breast density among Hispanic women. Int J Cancer 107:1012–1016. doi:10.1002/ijc.11495 PubMedCrossRef Lopez P, Van Horn L, Colangelo LA, Wolfman JA, Hendrick RE, Gapstur SM (2003) Physical inactivity and percent breast density among Hispanic women. Int J Cancer 107:1012–1016. doi:10.​1002/​ijc.​11495 PubMedCrossRef
75.
Zurück zum Zitat Meilahn EN, De Stavola B, Allen DS et al (1998) Do urinary oestrogen metabolites predict breast cancer? Br J Cancer 78:1250–1255PubMed Meilahn EN, De Stavola B, Allen DS et al (1998) Do urinary oestrogen metabolites predict breast cancer? Br J Cancer 78:1250–1255PubMed
77.
78.
Zurück zum Zitat De Cree C, Ball P, Seiditz B, Van Kranenburg G, Geuten P, Keizer HA (1998) Responsiveness of plasma 2- and 4-hydroxycatecholestrogens to training and to graduate submaximal and maximal exercise in an untrained woman. Interuniversity project on reproductive endocrinology in women and exercise. Int J Sports Med 19:20–25. doi:10.1055/s-2007-971874 PubMedCrossRef De Cree C, Ball P, Seiditz B, Van Kranenburg G, Geuten P, Keizer HA (1998) Responsiveness of plasma 2- and 4-hydroxycatecholestrogens to training and to graduate submaximal and maximal exercise in an untrained woman. Interuniversity project on reproductive endocrinology in women and exercise. Int J Sports Med 19:20–25. doi:10.​1055/​s-2007-971874 PubMedCrossRef
80.
Zurück zum Zitat Frisch RE, Snow RC, Johnson LA, Gerard B, Barbieri R, Rosen B (1993) Magnetic resonance imaging of overall and regional body fat, estrogen metabolism, and ovulation of athletes compared to controls. J Clin Endocrinol Metab 77:471–477. doi:10.1210/jc.77.2.471 PubMedCrossRef Frisch RE, Snow RC, Johnson LA, Gerard B, Barbieri R, Rosen B (1993) Magnetic resonance imaging of overall and regional body fat, estrogen metabolism, and ovulation of athletes compared to controls. J Clin Endocrinol Metab 77:471–477. doi:10.​1210/​jc.​77.​2.​471 PubMedCrossRef
81.
Zurück zum Zitat Snow RC, Barbieri RL, Frisch RE (1989) Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen. J Clin Endocrinol Metab 69:369–376PubMedCrossRef Snow RC, Barbieri RL, Frisch RE (1989) Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen. J Clin Endocrinol Metab 69:369–376PubMedCrossRef
82.
Zurück zum Zitat Bentz AT, Schneider CM, Westerlind KC (2005) The relationship between physical activity and 2-hydroxyestrone, 16α-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States). Cancer Causes Control 16:455–461. doi:10.1007/s10552-004-6256-6 PubMedCrossRef Bentz AT, Schneider CM, Westerlind KC (2005) The relationship between physical activity and 2-hydroxyestrone, 16α-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States). Cancer Causes Control 16:455–461. doi:10.​1007/​s10552-004-6256-6 PubMedCrossRef
84.
Zurück zum Zitat Campbell KL, Westerlind KC, Harber VJ, Bell GJ, Mackey JR, Courneya KS (2007) Effects of aerobic exercise training and estrogen metabolism in premenopausal women: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 16:731–739. doi:10.1158/1055-9965.EPI-06-0784 PubMedCrossRef Campbell KL, Westerlind KC, Harber VJ, Bell GJ, Mackey JR, Courneya KS (2007) Effects of aerobic exercise training and estrogen metabolism in premenopausal women: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 16:731–739. doi:10.​1158/​1055-9965.​EPI-06-0784 PubMedCrossRef
85.
Zurück zum Zitat Atkinson C, Lampe JW, Tworoger SS et al (2004) Effects of a moderate intensity exercise intervention on estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev 13:868–874PubMed Atkinson C, Lampe JW, Tworoger SS et al (2004) Effects of a moderate intensity exercise intervention on estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev 13:868–874PubMed
86.
Zurück zum Zitat De Cree C, Ball P, Seidlitz B, Van Kranenburg G, Geurten P, Keizer HA (1997) Responses of catecholestrogen metabolism to acute graded exercise in normal menstruating women before and after training. J Clin Endocrinol Metab 82:3342–3348. doi:10.1210/jc.82.10.3342 PubMedCrossRef De Cree C, Ball P, Seidlitz B, Van Kranenburg G, Geurten P, Keizer HA (1997) Responses of catecholestrogen metabolism to acute graded exercise in normal menstruating women before and after training. J Clin Endocrinol Metab 82:3342–3348. doi:10.​1210/​jc.​82.​10.​3342 PubMedCrossRef
87.
Zurück zum Zitat De Cree C, Van Kranenburg G, Geurten P, Fujimori Y, Keizer HA (1997) 4-Hydroxycatecholestrogen metabolism responses to exercise and training: possible implications for menstrual cycle irregularities and breast cancer. Fertil Steril 67:505–516. doi:10.1016/S0015-0282(97)80078-7 PubMedCrossRef De Cree C, Van Kranenburg G, Geurten P, Fujimori Y, Keizer HA (1997) 4-Hydroxycatecholestrogen metabolism responses to exercise and training: possible implications for menstrual cycle irregularities and breast cancer. Fertil Steril 67:505–516. doi:10.​1016/​S0015-0282(97)80078-7 PubMedCrossRef
89.
Zurück zum Zitat Greim H, Csanady G, Filser G et al (1995) Biomarkers as tools in human risk assessment. Clin Chem 41:1804–1808PubMed Greim H, Csanady G, Filser G et al (1995) Biomarkers as tools in human risk assessment. Clin Chem 41:1804–1808PubMed
93.
Zurück zum Zitat Fernandez SV, Wu YZ, Russo IH, Plass CP, Russo J (2006) The role of DNA methylation in estrogen-induced transformation of human breast epithelial cells. Proc Am Assoc Cancer Res 47:1590 Fernandez SV, Wu YZ, Russo IH, Plass CP, Russo J (2006) The role of DNA methylation in estrogen-induced transformation of human breast epithelial cells. Proc Am Assoc Cancer Res 47:1590
94.
Zurück zum Zitat Klein CB, Leszczynska J (2005) Estrogen-induced DNA methylation of E-cadherin & p16 in non-tumor breast cells. Proc Am Assoc Cancer Res 46:2744 Klein CB, Leszczynska J (2005) Estrogen-induced DNA methylation of E-cadherin & p16 in non-tumor breast cells. Proc Am Assoc Cancer Res 46:2744
95.
Zurück zum Zitat Lewis CM, Cler LR, Bu DW et al (2005) Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Clin Cancer Res 11:166–172PubMed Lewis CM, Cler LR, Bu DW et al (2005) Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Clin Cancer Res 11:166–172PubMed
97.
Zurück zum Zitat Thompson HJ (1994) Effect of exercise intensity and duration on the induction of mammary carcinogenesis. Cancer Res 54(Suppl):1960s–1963sPubMed Thompson HJ (1994) Effect of exercise intensity and duration on the induction of mammary carcinogenesis. Cancer Res 54(Suppl):1960s–1963sPubMed
98.
Zurück zum Zitat Guler G, Iliopoulos D, Han S-Y et al (2005) Hypermethylation patterns in the Fhit regulatory region are tissue specific. Mol Carcinogen 43:175–178. doi:10.1002/mc.20100 CrossRef Guler G, Iliopoulos D, Han S-Y et al (2005) Hypermethylation patterns in the Fhit regulatory region are tissue specific. Mol Carcinogen 43:175–178. doi:10.​1002/​mc.​20100 CrossRef
Metadaten
Titel
Physical activity as a negative modulator of estrogen-induced breast cancer
verfasst von
Yvonne M. Coyle
Publikationsdatum
01.12.2008
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 10/2008
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-008-9186-x

Weitere Artikel der Ausgabe 10/2008

Cancer Causes & Control 10/2008 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.